![Christopher Lee](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Christopher Lee
Technik-/Wissenschafts-/F&E-Leiter bei Mitralign, Inc.
Ursprung des Netzwerks ersten Grades von Christopher Lee
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Mitralign, Inc.
![]() Mitralign, Inc. Medical SpecialtiesHealth Technology Mitralign, Inc. operates as a valve repair company that engages in transcatheter annuloplasty system designed to treat both functional tricuspid regurgitation and mitral regurgitation. The Mitralign Percutaneous Annuloplasty System, MPAS, is intended for the treatment of symptomatic functional mitral regurgitation for annular reduction through tissue plication. The company was founded by Paul A. Spence and Richard P. Geoffrion in 2003 and is headquartered in Tewksbury, MA.
13
| Subsidiary | Medical Specialties | 13 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Christopher Lee
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
BOSTON SCIENTIFIC CORPORATION | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
Stanford University | College/University | Graduate Degree Masters Business Admin | |
X-Cell Medical, Inc.
![]() X-Cell Medical, Inc. Medical SpecialtiesHealth Technology X-Cell Medical, Inc. develops drugs for cardiovascular clinical applications. It focuses on delivery of drugs with safety and efficacy profiles for cardiovascular indications including restenosis, myocardial infarction and vulnerable plaque. The company was founded in 2002 and is headquartered in Monmouth Junction, NJ. | Medical Specialties | Director/Board Member Chairman | |
FlowMedica, Inc.
![]() FlowMedica, Inc. Medical SpecialtiesHealth Technology FlowMedica, Inc. develops intravascular systems and medical devices. The company's products include Benephit CV, PVSolo, PVMini, and XT Infusion systems. It also develops novel, proprietary, and minimally invasive intravascular systems for implementing Targeted Renal Therapy. The company was founded in 2002 and is headquartered in Fremont, CA. | Medical Specialties | Director/Board Member Director/Board Member | |
Salem State University | College/University | Masters Business Admin | |
Southern New Hampshire University | College/University | Doctorate Degree | |
The Brigham & Women's Hospital, Inc.
![]() The Brigham & Women's Hospital, Inc. Hospital/Nursing ManagementHealth Services The Brigham & Women's Hospital, Inc. provides health care services. The firm offers treatment for cancer, cardio vascular, neurosciences, orthopedic, arthritis, women's health and clinical services. The company was founded in 1980 and is headquartered in Boston, MA. | Hospital/Nursing Management | Corporate Officer/Principal | |
Harvard Mit Health Sciences & Technology | College/University | Corporate Officer/Principal | |
University of California, Irvine | College/University | Undergraduate Degree | |
Kenyon College | College/University | Undergraduate Degree | |
Babson College | College/University | Masters Business Admin | |
Georgetown University | College/University | Graduate Degree | |
STENTYS | Medical Specialties | Sales & Marketing | |
CBSET, Inc.
![]() CBSET, Inc. Miscellaneous Commercial ServicesCommercial Services CBSET, Inc. is a not-for-profit biomedical research institute located in Lexington, MA. The non-profit company's mission is to advance biomedical research through innovative, high-quality preclinical services to achieve the scientific, regulatory, and commercial goals of its sponsors. CBSET combines top-tier research with operational expertise by providing in vivo studies, in vitro studies, computational and 3D modeling, and complex histopathology services. The company's 40,000-foot, GLP-compliant, OLAW-assured, AAALAC-accredited facility includes vivaria, procedure rooms, catheterization/imaging labs, surgical and necropsy suites, histopathology, SEM, and a range of other technologies. | Miscellaneous Commercial Services | Chief Operating Officer | |
Robocath SAS
![]() Robocath SAS Miscellaneous Commercial ServicesCommercial Services Robocath SAS develops robotics medical devices for cardiac pathologies. It allows doctors to perform coronary angioplasties by controlling the catheters whilst seating behind a control station that is protected from X-rays. The company was founded by Philippe Bencteux in 2009 and is headquartered in Rouen, France. | Miscellaneous Commercial Services | Chief Executive Officer | |
OPSENS INC. | Medical Specialties | Director/Board Member | |
Khazanah Nasional Bhd. (Private Equity)
![]() Khazanah Nasional Bhd. (Private Equity) Investment ManagersFinance Khazanah Nasional Bhd. (Private Equity) (Khazanah Nasiona) is a Private Equity firm, a subsidiary of Khazanah Nasional Bhd. founded in 1994. The firm is headquartered in Malaysia. | Investment Managers | Corporate Officer/Principal | |
ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
American Institute of Toxicology, Inc.
![]() American Institute of Toxicology, Inc. Medical/Nursing ServicesHealth Services American Institute of Toxicology, Inc. operates a drug testing and toxicology laboratory. It provides custom-designed drug testing services, laboratory testing capabilities compliance testing, forensic toxicology drug testing, clinical testing, and prescription drug testing services. The company was founded by Michael A. Evans in 1990 and is headquartered in Denton, TX. | Medical/Nursing Services | Director/Board Member | |
Expanding Orthopedics, Inc.
![]() Expanding Orthopedics, Inc. Medical SpecialtiesHealth Technology Expanding Orthopedics, Inc. develops and markets orthopedic device products. The firm’s products include XPED pedicle screw system and FLXfit 3D expandable Cage. The company was founded by Mark M. Levy in 2001 and is headquartered in Atlanta, GA. | Medical Specialties | Director/Board Member | |
CS-Keys, Inc.
![]() CS-Keys, Inc. Medical SpecialtiesHealth Technology CS-Keys is the leader in discovery and development of cancer diagnostics based on the science of the DNA Synthesome. As the greatest potential for reducing mortality of cancer lies in the detection of asymptomatic, early stage disease, as well as for residual disease after treatment, the discovery of new markers for this purpose holds significant promise. CS-Keys patented caPCNA antibody may be a powerful ally in helping pathologists achieve this objective. CS-Keys, Inc. is a private, Indianapolis-based biotechnology company focused on the discovery and development of 3rd generation cancer-associated biomarkers using proteomics. These biomarkers may be used to create products to enhance the diagnosis and treatment of patients with cancer. CS-Keys was founded in early 2006 to develop and commercialize products based on the founders research and licensed from Indiana University. | Medical Specialties | Chairman | |
University of Evansville | College/University | Undergraduate Degree | |
Remon Medical Technologies, Inc.
![]() Remon Medical Technologies, Inc. Medical SpecialtiesHealth Technology Remon Medical Technologies, Inc. develops and commercializes assessment and treatment implants. It has developed applications for patient management, post-operative monitoring, nerve and tissue stimulation and local drug delivery. The company was founded by Eyal Doron, Yariv Porat and Yossi Tzaliach in 1997 and is headquartered in Waltham, MA. | Medical Specialties | Director/Board Member | |
Triathlon Medical Venture Partners LLC
![]() Triathlon Medical Venture Partners LLC Investment ManagersFinance Triathlon Medical Venture Partners LLC (Triathlon Medical Venture) is a venture capital firm founded in 2004 by Dennis Costello and John Rice. The firm is headquartered in Cincinnati, Ohio with additional offices in Indianapolis and Louisville. | Investment Managers | Private Equity Investor | |
Xeraya Capital Sdn. Bhd.
![]() Xeraya Capital Sdn. Bhd. Investment ManagersFinance Xeraya Capital Sdn. Bhd. (Xeraya Capital) is a venture capital firm founded in 2006 by Amirul Fares Wan Zahir. The firm is headquartered in Kuala Lumpur, Malaysia. | Investment Managers | Private Equity Investor | |
CONFORMIS, INC. | Medical Specialties | Director/Board Member | |
NATUS MEDICAL INCORPORATED | Medical Specialties | Director/Board Member | |
Gradient Denervation Technologies SAS
![]() Gradient Denervation Technologies SAS Miscellaneous Commercial ServicesCommercial Services Gradient Denervation Technologies SAS engages in research and development in other physical and natural sciences. The company is headquartered in Paris, France. | Miscellaneous Commercial Services | Director/Board Member | |
ABIOMED, INC. | Medical Specialties | Corporate Officer/Principal | |
MIROMATRIX MEDICAL INC. | Biotechnology | Director/Board Member | |
Dearca Strategic Solutions LLC | Founder | ||
Covidien Unlimited Co.
![]() Covidien Unlimited Co. Medical SpecialtiesHealth Technology Covidien Unlimited Co. engages in the development, manufacture, and sale of healthcare products for use in clinical and home settings. It operates through Medical Devices and U.S. Medical Supplies segments. The Medical Devices segment involves in the distribution of surgical solutions, peripheral vascular and neurovascular therapies, patient monitoring products, and airway and ventilation products. The U.S. Medical Supplies segment includes marketing of nursing care, medical surgical, SharpSafety brand, and original equipment manufacturer (OEM) products. The company was founded in 1967 and is headquartered in Dublin, Ireland. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
University of Manitoba | College/University | Graduate Degree | |
St. Olaf College | College/University | Undergraduate Degree | |
TRIVARX LIMITED | Packaged Software | Director/Board Member | |
Vascular Therapies, Inc.
![]() Vascular Therapies, Inc. Medical SpecialtiesHealth Technology Vascular Therapies, Inc. operates as a biopharmaceutical firm that develops and commercialize treatments of patients requiring an AV fistula for dialysis. It provides plan on the hemodialysis vascular access indication. The company was founded by Sriram Iyer in 2001 and is headquartered in Cresskill, NJ. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
SURMODICS, INC. | Medical Specialties | Director/Board Member | |
University of Southern Maine | College/University | Undergraduate Degree | |
The Hong Kong Polytechnic University | College/University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 40 |
Frankreich | 4 |
Kanada | 3 |
Malaysia | 3 |
Israel | 2 |
Sektoral
Health Technology | 26 |
Consumer Services | 14 |
Commercial Services | 5 |
Finance | 4 |
Health Services | 3 |
Operativ
Director/Board Member | 59 |
Corporate Officer/Principal | 18 |
Undergraduate Degree | 10 |
Founder | 10 |
Independent Dir/Board Member | 9 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Dan Cole | 30 |
Yuval Binur | 21 |
Aditya Puri | 15 |
Lisa Heine | 14 |
Martinus Adrianus van Osch | 12 |
Carrie J. L. Bates | 11 |
Donald J. Webber | 9 |
Adam Groothuis | 8 |
John M. MacMahon | 5 |
Lucien Goffart | 4 |
David R. Schleifer | 4 |
Yixin He | 3 |
Scott Oppenheim | 1 |
- Börse
- Insiders
- Christopher Lee
- Unternehmensverbindungen